BCL2L1 and B-cell chronic lymphocytic leukemia: Having confirmed the direct binding of STAT3 and STAT6 to the Bcl‐XL promoter in HEK293T cells, we next aimed to test the DNA‐binding capacity of STAT3 and STAT6 in primary CLL cells.